官方服务：
资源简介：
Yale Triple Negative Breast Cancer Cohort
应用场景：
创建时间：
2013-08-15
相关数据集
Genomic Regulation of Invasion by STAT3 in Triple Negative Breast Cancer
Breast cancer is a heterogeneous disease comprised of four molecular subtypes defined by whether the tumor-originating cells are luminal or basal epithelial cells. Breast cancers arising from the lumi
NIAID Data Ecosystem70
SMARCA4 loss-of-function induces cisplatin resistance to activate YAP1-dependent epithelial-to-mesenchymal in triple negative breast cancer
We report transcriptome profiling (RNA-seq) for SMARA4 knock-out to elucidate the association with cisplatin-resistance and SMARCA4 loss-of-function using triple negative breast cancer cell lines. Ove
NIAID Data Ecosystem50
Baseline demographics and risk factors in both cohorts (patients attending 6-month follow-up).
*observational patients willing to participate in a future support program.**without DWI lesion in MRI.
Figshare2015-12-02 更新20
ChIP-seq of E4F1 in SUM159 triple negative breast cancer cell line
E4F1 is a ubiquitously expressed zinc-finger protein of the Gli-Kruppel family that was first identified, more than 30 years ago, as a cellular target of the adenoviral oncoprotein E1A13S (Ad type V),
NIAID Data Ecosystem60
Synergy of chemotherapy and macrophage depletion leads to T cell memory activation and durable triple negative breast cancer regression
Chemotherapy and macrophage depletion leads to T cell memory activation and durable triple negative breast cancer regression in p53 null mouse models. Overall design: RNA-seq was performed on 15 'p53
NIAID Data Ecosystem20
